RUNX1 and leukemia: Five independent mouse CM+ leukemia samples were treated with 1 μM entinostat, an HDAC1 inhibitor, or DMSO for 24 h, nuclear lysates prepared, RUNX1 immunoprecipitated, and the precipitate analyzed by mass spectrometry (Fig. 1A).